Skip to menu Skip to content Skip to footer
Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 

Overview

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Works

Search Professor Gerald Holtmann’s works on UQ eSpace

663 works between 1937 and 2026

241 - 260 of 663 works

2020

Conference Publication

PREVALENCE OF METHANE POSITIVE SMALL INTESTINAL BACTERIAL OVERGROWTH IN IBS AND IBD: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gandhi, Arjun, Shah, Ayesha, Jones, Michael P., Koloski, Natasha A., Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald J. (2020). PREVALENCE OF METHANE POSITIVE SMALL INTESTINAL BACTERIAL OVERGROWTH IN IBS AND IBD: A SYSTEMATIC REVIEW AND META-ANALYSIS. Crohn's and Colitis Congress, Austin Tx, Jan 23-25, 2020. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

PREVALENCE OF METHANE POSITIVE SMALL INTESTINAL BACTERIAL OVERGROWTH IN IBS AND IBD: A SYSTEMATIC REVIEW AND META-ANALYSIS

2020

Conference Publication

Self-reported non-celiac wheat sensitivity in patients with chronic unexplained (functional) gastrointestinal symptoms: gut function, immune activation and duodenal mucosa associated microbiome

Shah, Ayesha, Talley, Nicholas J., Kang, Seungha, Do, Anh, Walker, Marjorie M., Shanahan, Erin R., Koloski, Natasha A., Jones, Michael P., Keely, Simon, Morrison, Mark and Holtmann, Gerald J. (2020). Self-reported non-celiac wheat sensitivity in patients with chronic unexplained (functional) gastrointestinal symptoms: gut function, immune activation and duodenal mucosa associated microbiome. AGA 2020, Online, 2020. Philadelphia, PA United States: Elsevier . doi: 10.1016/s0016-5085(20)31900-4

Self-reported non-celiac wheat sensitivity in patients with chronic unexplained (functional) gastrointestinal symptoms: gut function, immune activation and duodenal mucosa associated microbiome

2020

Conference Publication

Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease

Shah, Ayesha, Talley, Nicholas J., Koloski, Natasha A., Macdonald, Graeme A., Kendall, Bradley J., Shanahan, Erin R., Walker, Marjorie M., Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2020). Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease. Crohn's and Colitis Congress, Austin, TX United States, 23-25 January 2020. Philadelphia, PA United States: Elsevier.

Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease

2020

Conference Publication

IS SMALL INTESTINAL DYSBIOSIS (SIBO) RELATED TO IMPROVEMENT OF EPIGASTRIC PAIN, EARLY SATIETY AND POSTPRANDIAL PAIN IN RESPONSE TO ANTIMICROBIAL THERAPY WITH RIFAXIMIN IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS?

Shah, Ayesha, Talley, Nicholas J., Koloski, Natasha A., Walker, Marjorie M., Callaghan, Gavin, Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2020). IS SMALL INTESTINAL DYSBIOSIS (SIBO) RELATED TO IMPROVEMENT OF EPIGASTRIC PAIN, EARLY SATIETY AND POSTPRANDIAL PAIN IN RESPONSE TO ANTIMICROBIAL THERAPY WITH RIFAXIMIN IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS?. Crohn's and Colitis Congress, Austin Tx, Jan 23-25, 2020. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

IS SMALL INTESTINAL DYSBIOSIS (SIBO) RELATED TO IMPROVEMENT OF EPIGASTRIC PAIN, EARLY SATIETY AND POSTPRANDIAL PAIN IN RESPONSE TO ANTIMICROBIAL THERAPY WITH RIFAXIMIN IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS?

2020

Journal Article

Platelet activating factor receptor acts to limit colitis-induced liver inflammation

Liu, Gang, Baird, Alan W., Parsons, Marie J., Fan, Kening, Skerrett-Byrne, David A., Nair, Prema M., Makanyengo, Samwel, Chen, Jinbiao, Neal, Rachel, Goggins, Bridie J., Tay, Hock, Mathe, Andrea, Soh, Wai S., Minahan, Kyra, Hansbro, Phil M., Nixon, Brett, McCaughan, Geoffrey W., Holtmann, Gerald, Colgan, Sean P. and Keely, Simon (2020). Platelet activating factor receptor acts to limit colitis-induced liver inflammation. The FASEB Journal, 34 (6), 7718-7732. doi: 10.1096/fj.201901779R

Platelet activating factor receptor acts to limit colitis-induced liver inflammation

2020

Conference Publication

Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease

Shah, Ayesha, Talley, Nicholas, Koloski, Natasha, Shanahan, Erin, Walker, Marjorie, Keely, Simon, Jones, Michael, Morrison, Mark and Holtmann, Gerald (2020). Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease. Meeting of the Federation of Neurogastroenterology and Motility, Adelaide, Australia, 25 – 28 March 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Quantitative PCR as a novel approach to determine small intestinal bacterial load in health and disease

2020

Conference Publication

Peroral endoscopic myotomy for achalasia: predictors of treatment response

Ben Jacob, Ronen, Bradbear, Joseph, Taylor, Andrew, Shah, Ayesha, Hourigan, Luke F. and Holtmann, Gerald (2020). Peroral endoscopic myotomy for achalasia: predictors of treatment response. Meeting of the Federation of Neurogastroenterology and Motility, Adelaide, SA Australia, 25–28 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Peroral endoscopic myotomy for achalasia: predictors of treatment response

2020

Journal Article

Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3)

Kutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2020). Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3). Indian Journal of Gastroenterology, 38 (6), 557-557. doi: 10.1007/s12664-019-01010-0

Correction to: An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy (Indian Journal of Gastroenterology, (2019), 38, 3, (268-272), 10.1007/s12664-019-00966-3)

2020

Journal Article

Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies

Shah, Ayesha, Talley, Nicholas J., Jones, Michael, Kendall, Bradley, Koloski, Natasha, Walker, Marjorie, Morrison, Mark and Holtmann, Gerald J. (2020). Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. American Journal of Gastroenterology, 115 (2), 190-201. doi: 10.14309/ajg.0000000000000504

Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies

2020

Journal Article

Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia

Potter, Michael D. E., Jones, Michael P., Walker, Marjorie M., Koloski, Natasha A., Keely, Simon, Holtmann, Gerald and Talley A. C., Nicholas J. (2020). Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia. Medical Journal of Australia, 212 (3) mja2.50458, 126-131. doi: 10.5694/mja2.50458

Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia

2020

Journal Article

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic

Holtmann, Gerald, Quigley, Eamonn M., Shah, Ayesha, Camilleri, Michael, Tan, Victoria P.Y., Gwee, Kok Ann, Sugano, Kentaro, Sollano, Jose D., Fock, Kwong M., Ghoshal, Uday C., Chen, Minhu, Dignass, Axel and Cohen, Henry (2020). “It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic. Journal of Gastroenterology and Hepatology, 35 (7), 1117-1123. doi: 10.1111/jgh.15133

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic

2020

Conference Publication

Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms

Shah, Ayesha, Talley, Nicholas, Kang, Seungha, Do, Anh, Walker, Marjorie, Koloski, Natasha, Jones, Michael, Keely, Simon, Morrison, Mark and Holtmann, Gerald (2020). Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms. Meeting of the Federation of Neurogastroenterology and Motility, Adelaide, SA Australia, 25 – 28 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms

2020

Journal Article

Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease

Shah, Ayesha, Talley, Nicholas J., Koloski, Natasha, Macdonald, Graeme A., Kendall, Bradley J., Shanahan, Erin R., Walker, Marjorie M., Keely, Simon, Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2020). Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 52 (1), 155-167. doi: 10.1111/apt.15786

Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease

2020

Conference Publication

Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease

Shah, Ayesha, Kang, Seungha, Tyson, Gene, Zaugg, Julian, Hugenholtz, Phil, Morrison, Mark and Holtmann, Gerald J. (2020). Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease. Crohn's and Colitis Congress, Austin, TX, United States, 23-25 January 2020. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(20)32052-7

Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease

2020

Journal Article

Is there a causal link between psychological disorders and functional gastrointestinal disorders?

Koloski, Natasha, Holtmann, Gerald and Talley, Nicholas J. (2020). Is there a causal link between psychological disorders and functional gastrointestinal disorders?. Expert Review of Gastroenterology and Hepatology, 14 (11), 1-13. doi: 10.1080/17474124.2020.1801414

Is there a causal link between psychological disorders and functional gastrointestinal disorders?

2020

Journal Article

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

2019

Conference Publication

Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms

Bray, Nicola, Koloski, Natasha, Jones, Michael, Do, Anh, Talley, Nicholas, Billin, Abbi, Bettens, Gemma, Mcallister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Jeff and Holtmann, Gerald (2019). Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.

Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms

2019

Conference Publication

Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )

Shah, Ayesha, Kutyla, Marguerite, Hansen, Teressa, Virgo, Kate, Koloski, Natasha, Huelsen-Katz, Alexander, Martin, Neal, Maqboul, Nadia, Chao, Che-Yung, Whaley, Amanda, Hourigan, Luke and Holtmann, Gerald (2019). Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus ). Asia Pacific Digestive Week (APDW), Kolkata, India, 12–15 December 2019. Richmond, VIC Australia: John Wiley & Sons.

Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )

2019

Journal Article

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

2019

Conference Publication

A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study

Bray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., McAllister, S., Pang, S., Arthur, L., Campos, J., Chao, C., Catague, R., Whalley, A., MacDonald, G. and Holtmann, G. (2019). A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.

A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study

Funding

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant

Past funding

  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Supervision

Availability

Professor Gerald Holtmann is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Honorary Professor Paul Clark

  • Doctor Philosophy

    Investigating the Role of Exercise in Managing Disorders of the Gut Brain Interaction

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    Targeting the gastrointestinal mucosa associated microbiome to improve clinical outcomes

    Associate Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

Completed supervision

Media

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au